Trial · NCT05064735
Adverse events104
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 104
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Semaglutide 2.4 mg | 8 | 269 | 11 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 13 | 135 | 13 |
| other | COVID-19 | Infections and infestations | Semaglutide 2.4 mg | 50 | 269 | 54 |
| other | COVID-19 | Infections and infestations | Placebo | 30 | 135 | 31 |
| other | Constipation | Gastrointestinal disorders | Semaglutide 2.4 mg | 32 | 269 | 35 |
| other | Constipation | Gastrointestinal disorders | Placebo | 7 | 135 | 7 |
| other | Diarrhoea | Gastrointestinal disorders | Semaglutide 2.4 mg | 21 | 269 | 32 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 7 | 135 | 8 |
| other | Headache | Nervous system disorders | Semaglutide 2.4 mg | 16 | 269 | 18 |
| other | Headache | Nervous system disorders | Placebo | 5 | 135 | 5 |
| other | Nausea | Gastrointestinal disorders | Semaglutide 2.4 mg | 59 | 269 | 109 |
| other | Nausea | Gastrointestinal disorders | Placebo | 12 | 135 | 16 |
| other | Upper respiratory tract infection | Infections and infestations | Semaglutide 2.4 mg | 12 | 269 | 12 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 7 | 135 | 8 |
| other | Vomiting | Gastrointestinal disorders | Semaglutide 2.4 mg | 21 | 269 | 30 |
| other | Vomiting | Gastrointestinal disorders | Placebo | 1 | 135 | 1 |
| serious | Abdominal abscess | Infections and infestations | Semaglutide 2.4 mg | 0 | 269 | 0 |
| serious | Abdominal abscess | Infections and infestations | Placebo | 1 | 135 | 1 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Semaglutide 2.4 mg | 1 | 269 | 1 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Placebo | 0 | 135 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05064735/events